Searched for
DRUG DISCOVERY STARTUP
Scanning cancer, up close & personal: A revolution is underway in cancer diagnosisA gene-based test called next-generation sequencing can identify precise mutations, which can then be treated with targeted therapies. Sinc...- Karnataka explores biotech financing framework, AI-led innovation to support sector growthKarnataka is developing a dedicated support framework for its biotechnology sector, encompassing funding, mentoring, and regulatory guidanc...
- India pitches quantum computing collaboration with Russia under national missionIndia is looking to partner with Russia on quantum computing. This collaboration is part of India's ambitious National Quantum Mission. The...
- Infosys-backed 4baseCare raises Rs 128 crore, plans to take its cancer testing platform globalPrecision oncology startup 4baseCare has raised Rs 128 crore. This funding will expand its genomics labs globally and scale its AI platform...
- India’s quantum opportunity: Turning scale into strategic advantageIndia has a structural advantage in quantum computing. Its size inherently creates challenging optimisation issues, offering a practical te...
- Intel spinout Articul8 eyes $50 million for India heritage AI ventureArticul8, a spin-off from Intel, is raising $30-50 million to establish an India-based AI entity focused on traditional knowledge systems l...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Mark Zuckerberg's philanthropic venture unveils AI world model for drug discoveryBiohub, a venture by Mark Zuckerberg and Priscilla Chan, has launched a protein biology world model. This advanced AI tool aims to speed up...
- Amaravati still under construction, but Quantum Valley project already luring deep tech startups, scientistsAmaravati, a new city in Andhra Pradesh, is becoming a hub for quantum computing. A technology park called Quantum Valley is attracting sci...
- DeepMind CEO Demis Hassabis’ Isomorphic Labs raises $2.1 billion led by Thrive CapitalAI-driven drug discovery firm Isomorphic Labs secured a massive $2.1 billion in Series B funding. This capital will fuel the expansion of t...
- Google’s Isomorphic Labs to raise over $2 billion in new fundingAlphabet's AI drug discovery firm, Isomorphic Labs, is reportedly close to securing over $2 billion in new funding, led by Thrive Capital. ...
- ET Most Innovative AI Product Awards 2026: Honouring AI Innovations reshaping Life Sciences & Pharma ResearchThe Life Sciences & Pharma category at the ET Most Innovative AI Product Awards 2026. Recognises organisations leveraging AI to accelerate ...
- The alchemist of Bengaluru: Kiran Mazumdar-Shaw began from a garageKiran Mazumdar-Shaw has named her niece Claire Mazumdar as successor, setting up a gradual leadership transition at Biocon. A pioneer who b...
- OpenAI launches AI model GPT-Rosalind for life sciences researchThe GPT-Rosalind, named after 20th-century British scientist Rosalind Franklin, is designed to support research across biochemistry, drug ...
- Deloitte launches quantum tech facility at IIT BombayDeloitte India has launched a new quantum technology facility at IIT Bombay. This center, named QCoDE, aims to boost quantum adoption for I...
- Anthropic acquires Coefficient Bio for nearly $400 million: ReportAnthropic acquires startup Coefficient Bio for about $400 million: report
- Drug discovery startup Peptris raises $1 million funding from Speciale Invest, othersUsing advanced AI, Peptris sifts through large data sets to identify and develop potential drug candidates quickly and cost-effectively, re...
- Anti-diabetes Molecules: Connexios inks licence deal with German pharma major Boehringer IngelheimFor Connexios, this sale of its anti-diabetes molecules to Boehringer Ingelheim is the first out-licensing deal by an Indian life-sciences ...
- Connexios, India’s first drug-discovery product startup signs first out-licensing deal; marks a milestoneConnexios, India’s first drug-discovery product startup, has signed its 1st out-licensing deal, marking a milestone for the Indian pharma i...
- Infosys founder NS Raghavan's venture investing arm invests Rs 100 crore in ConnexiosIn 2003, Nadathur Holdings, the venture investing arm of NS Raghavan, made its first investment in Connexios, a small drug discovery startu...
Load More
